RCL

Royal Caribbean Group
Hotels, Resorts & Cruise Lines · Consumer Discretionary · as of 2026-11-20
Last close
$301.00
-0.7% on the session
1-year return
+19.9%
+18.8% over six months
Volatility
48.1%
annualized, trailing year
Max drawdown
-32.7%
worst peak to trough, 1y
What the numbers say

Royal Caribbean Group is a hotels, resorts & cruise lines name in the consumer discretionary sector. Over the past year it returned +19.9%, against +3.3% over three months and +5.2% over one. It trades 5.3% above its 200-day average, so the longer trend is confirming recent strength. Annualized volatility of 48.1% is above the market's typical range.

Its worst peak-to-trough decline over the year was -32.7%, and it has traded a median $573M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.45 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Consumer Discretionary#22 of 47
Stronger than 54% of its sector on the momentum profile
Across the whole index#219 of 497

How RCL scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 7 others in Hotels, Resorts & Cruise Lines.

Start a free 7-day trial
Full metrics
1 day-0.7%
1 week-6.9%
1 month+5.2%
3 months+3.3%
6 months+18.8%
1 year+19.9%
12-1 momentum+14.0%
Volatility (1y, annualized)48.1%
Max drawdown (1y)-32.7%
Distance vs 200-day average+5.3%
Return per unit of risk0.41
Median daily dollar volume$573M
Free newsletter

Get RCL when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.